To compare the efficacy and safety of Aggrenox®(25 mg aspirin/200 mg extended-release dipyridamole) with Clopidogrel (Plavix®), and to compare Micardis® (telmisartan) with placebo in in the presence of background anti-hypertensive treatment in the prevention of recurrent stroke.



Randomized Evaluation of Long term therapy comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel group, non- inferiority trial.



A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation.



To establish whether a policy of earlier surgical evacuation of hematomas in selected patients with spontaneous lobar ICH will improve outcome compared to a policy of initial conservative treatment.



To determine whether lowering plasma homocysteine concentrations by the administration of vitamin supplements (folic acid 2 mg, B6 25 mg, B12 500 μg) will reduce the incidence of vascular sequelae following recent stroke or transient ischemic attacks (TIA).



Last Updated ( Tuesday, 25 August 2015 13:16 )